GLP-1 Injections Recalled Nationwide over Concerning Reason

. . .A popular weight-loss shot has been recalled across the country by the Food and Drug Administration due to potential contamination.

Apothecary Pharma, the US-based compounding pharmacy that issued the initial recall back in September, had already been on the agency’s radar and previously received a warning.

Apothecary Pharma is recalling 22 vials of its compounded tirzepatide, the active ingredient in Mounjaro and Zepbound, though these brand-name drugs aren’t affected by the recall.

Even if you didn’t buy directly from Apothecary Pharma, your medication could still be affected.

The company reportedly supplies compounded tirzepatide to several telehealth providers, so check your vial’s label for the manufacturer and lot number. (Read more from “GLP-1 Injections Recalled Nationwide over Concerning Reason” HERE)